SCHEMBL29625757

SCHEMBL29625757

CCO/N=C/c1c2c(O)c3c(O)c(C)c4c(c3c1O)C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)N2)O4

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.80
▸ ABCB11 O95342 3/20 0.80
▸ GAA P10253 3/20 0.80
▸ MAPK1 P28482 3/20 0.80
▸ ALDH1A1 P00352 2/20 0.80
▸ KDM4E B2RXH2 2/20 0.80
▸ MEN1 O00255 2/20 0.80
▸ KMT2A Q03164 2/20 0.80
▸ TDP1 Q9NUW8 2/20 0.80
▸ ABCC3 O15438 2/20 0.80
▸ ABCC4 O15439 2/20 0.80
▸ ABCC2 Q92887 2/20 0.80
▸ SLCO2B1 O94956 2/20 0.80
▸ CHRM1 P11229 2/20 0.80
▸ TBXA2R P21731 2/20 0.80
▸ ADRA1A P35348 2/20 0.80
▸ SLCO1A2 P46721 2/20 0.80
▸ SLCO1B3 Q9NPD5 2/20 0.80
▸ SLCO1B1 Q9Y6L6 2/20 0.80
▸ NR1I2 O75469 2/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29996898 0.95 ABCB11 (0.76) MAPTABCB11GAAMAPK1ALDH1A1
SCHEMBL30141019 0.94 ABCB11 (0.75) MAPTABCB11GAAMAPK1ALDH1A1
SCHEMBL29477247 0.94 ABCB11 (0.77) MAPTABCB11GAAMAPK1ALDH1A1
SCHEMBL29477244 0.94 ABCB11 (0.77) MAPTABCB11GAAMAPK1ALDH1A1
SCHEMBL29625733 0.94 MAPT (0.78) MAPTABCB11GAAMAPK1ALDH1A1
SCHEMBL23510705 0.94 MAPT (0.83) MAPTABCB11GAAMAPK1ALDH1A1
SCHEMBL23541652 0.94 MAPT (0.83) MAPTABCB11GAAMAPK1ALDH1A1
SCHEMBL30478471 0.94 ABCB11 (0.76) MAPTABCB11GAAMAPK1ALDH1A1
SCHEMBL29477253 0.94 ABCB11 (0.76) MAPTABCB11GAAMAPK1ALDH1A1
SCHEMBL30248384 0.94 ABCB11 (0.76) MAPTABCB11GAAMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115176024-A Astaxanthin high-producing strain of phaffia rhodozyma 纳斯特姆科技有限公司 2022-10-11 — — CN claimed
US-20220290119-A1 Astaxanthin Over-Producing Strains of Phaffia Rhodozyma NEXTFERM TECHNOLOGIES LTD. (IL) 2022-09-15 — — US claimed
EP-4004225-A1 ASTAXANTHIN OVER-PRODUCING STRAINS OF PHAFFIA RHODOZYMA NextFerm Technologies Ltd. (IL) 2022-06-01 — — EP claimed
CN-119081926-A Bifidobacterium adolescentis AF91-08b2A and application thereof in relieving ulcerative colitis 昆明医科大学第一附属医院(云南省皮肤病医院) 2024-12-06 — — CN disclosed
US-20240336559-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-10-10 — — US disclosed
EP-4392025-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS The Research Foundation for The State University of New York (US) 2024-07-03 — — EP disclosed
WO-2023060161-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-04-13 — — WO disclosed
CN-115176024-A Astaxanthin high-producing strain of phaffia rhodozyma 纳斯特姆科技有限公司 2022-10-11 — — CN disclosed
US-20220290119-A1 Astaxanthin Over-Producing Strains of Phaffia Rhodozyma NEXTFERM TECHNOLOGIES LTD. (IL) 2022-09-15 — — US disclosed
EP-4004225-A1 ASTAXANTHIN OVER-PRODUCING STRAINS OF PHAFFIA RHODOZYMA NextFerm Technologies Ltd. (IL) 2022-06-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220290119-A1 Astaxanthin Over-Producing Strains of Phaffia Rhodozyma RPIA, FDFT1, CYP51A1 MAPT 4438/4885ABCB11 2255/4885GAA 1357/4885
US-20240336559-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS S1PR3, ERG28, CBR3 MAPT 4313/4885ABCB11 2928/4885GAA 3659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback